Drug Trial Radar · NCT07038200
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Jun 10, 2025
Primary completion
May 2028
Study completion Jul 2028
Sponsor
- Lead sponsor
- Avidity Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
Conditions
- Facioscapulohumeral Muscular Dystrophy
- FSHD
- FSHD - Facioscapulohumeral Muscular Dystrophy
- FSHD1
- FSHD2
- Fascioscapulohumeral Muscular Dystrophy
- Fascioscapulohumeral Muscular Dystrophy Type 1
- Fascioscapulohumeral Muscular Dystrophy Type 2
- Facioscapulohumeral Muscular Dystrophy 1
- Facioscapulohumeral Dystrophy
- Facio-Scapulo-Humeral Dystrophy
- Facioscapulohumeral Muscular Dystrophy 2
- Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
- FSH Muscular Dystrophy
- Landouzy Dejerine Dystrophy
- Landouzy-Dejerine Muscular Dystrophy
- Landouzy-Dejerine Syndrome
Interventions
AOC-1020Drug
Del-brax will be administered by intravenous (IV) infusion.
PlaceboDrug
Placebo will be administered by intravenous (IV) infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline to Week 78 in Quantitative Muscle Testing (QMT) total composite score (PPN)Time frame: Baseline through Week 78
Locations
46 sites in 10 countries. Site status is shown where the registry gives one.
University of California Irvine
Orange, California · Active not recruiting
Stanford University
Palo Alto, California · Active not recruiting
University of Colorado
Denver, Colorado · Active not recruiting
University of Florida
Gainesville, Florida · Active not recruiting
University of Iowa
Iowa City, Iowa · Active not recruiting
Kansas University Medical Center
Kansas City, Kansas · Active not recruiting
Kennedy Krieger Institute
Baltimore, Maryland · Active not recruiting
University of Massachusetts
Worcester, Massachusetts · Active not recruiting
University of Rochester Medical Center
Rochester, New York · Active not recruiting
Duke University
Durham, North Carolina · Active not recruiting
Ohio State University
Columbus, Ohio · Active not recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Active not recruiting
University of Texas Health Science Center at San Antonio
San Antonio, Texas · Active not recruiting
Virginia Commonwealth University
Richmond, Virginia · Active not recruiting
University of Calgary - Cumming School of Medicine
Calgary, Alberta, Canada · Recruiting
University of Alberta Hospital
Edmonton, Alberta, Canada · Recruiting
The Ottawa Hospital
Ottawa, Ontario, Canada · Recruiting
Genge Partners Inc
Montreal, Quebec, Canada · Recruiting
Aarhus University Hospital
Aarhus, Denmark · Not yet recruiting
Rigshospitalet
Copenhagen, Denmark · Recruiting
Centre de Reference des Maladies Neuromusculaires et de la SLA - AP-HM Hopital de La Timone
Marseille, France · Not yet recruiting
CHU de Montpellier - Hopital Gui de Chauliac
Montpellier, France · Not yet recruiting
CHU de Nice - Hopital Pasteur 2 - Centre de reference des Maladies Neuromusculaires
Nice, France · Not yet recruiting
AP-HP Hopital Pitie-Salpetriere
Paris, France · Recruiting
Universitaetsklinikum Bonn
Bonn, Germany · Recruiting
Georg-August-Universitaet Goettingen Stiftung oeffentlichen Rechts Universitaetsmedizin Goettingen
Göttingen, Germany · Recruiting
Klinikum der Ludwig-Maximilians-Universitaet Muenchen
München, Germany · Recruiting
Universitaetsklinikum Ulm
Ulm, Germany · Recruiting
Fondazione Serena ETS - Centro Clinico NeMO Milano
Milan, Italy · Recruiting
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy · Recruiting
Azienda Ospedaliero-Universitaria Sant'Andrea
Roma, Italy · Recruiting
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore
Roma, Italy · Recruiting
National Hospital Organization Osaka Toneyama Medical Center
Osaka, Japan · Recruiting
The University of Osaka Hospital
Osaka, Japan · Recruiting
National Hospital Organization Sendai Nishitaga Hospital
Sendai, Japan · Recruiting
National Center of Neurology and Psychiatry
Tokyo, Japan · Recruiting
Academisch Ziekenhuis Leiden
Leiden, Netherlands · Recruiting
Stichting Radboud Universitair Medisch Centrum
Nijmegen, Netherlands · Recruiting
Hospital Universitari de Bellvitge
Barcelona, Spain · Recruiting
Hospital Universitario Vall d'Hebron
Barcelona, Spain · Recruiting
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.